Filtered By:
Specialty: Cardiology
Management: Health Insurance
This page shows you your search results in order of relevance. This is page number 9.
Order by Relevance | Date
Total 191 results found since Jan 2013.
Level of Blood Pressure Control and Cardiovascular Events SPRINT Criteria Versus the 2014 Hypertension Recommendations
BackgroundBlood pressure (BP) targets from the SPRINT (Systolic Blood Pressure Intervention Trial) differ from targets of the 2014 hypertension (HTN) recommendations of the Eighth Joint National Committee.ObjectivesThe goal of this study was to estimate the proportion of hypertensive adults with who would meet BP goals under the SPRINT criteria and under the 2014 recommendations, and to determine related effects on cardiovascular morbidity and mortality.MethodsWe used data from the Korean National Health and Nutrition Examination Survey of 2008 to 2013 (n = 13,346), as well as the Korean National Health Insurance Service...
Source: Journal of the American College of Cardiology - June 14, 2016 Category: Cardiology Source Type: research
Incidence and Risk Factors for Atrial Fibrillation in Korea: the National Health Insurance Service Database (2002-2010).
CONCLUSION: Incidence of AF increased with age and was higher in men than in women. A larger proportion of AF events was attributable to hypertension than to other co-morbidities.
PMID: 27482260 [PubMed]
Source: Korean Circulation Journal - August 4, 2016 Category: Cardiology Tags: Korean Circ J Source Type: research
Thromboembolic, Bleeding, and Mortality Risks of Rivaroxaban and Dabigatran in Asians With Nonvalvular Atrial Fibrillation
BackgroundIt is unclear whether the non –vitamin K antagonist oral anticoagulant agents rivaroxaban and dabigatran are superior to warfarin for efficacy and safety outcomes in Asians with nonvalvular atrial fibrillation (NVAF).ObjectivesThe aim of this study was to compare the risk for thromboembolic events, bleeding, and mortality associated with rivaroxaban and dabigatran versus warfarin in Asians with NVAF.MethodsA nationwide retrospective cohort study was conducted of consecutive patients with NVAF taking rivaroxaban (n = 3,916), dabigatran (n = 5,921), or warfarin (n = 5,251) using data collected from the Taiwan...
Source: Journal of the American College of Cardiology - September 20, 2016 Category: Cardiology Source Type: research
The Trends of Atrial Fibrillation-Related Hospital Visit and Cost, Treatment Pattern and Mortality in Korea: 10-Year Nationwide Sample Cohort Data.
CONCLUSION: During the last decade, AF-related hospitalization and outpatient clinic visits have increased with the increase of many other comorbidities, whereas the rate of anticoagulation did not improved. Although mortality in patients with AF showed a modest decrease from 2004 to 2013, proper anticoagulation therapy is warranted for the improvement of public health.
PMID: 28154592 [PubMed - in process]
Source: Korean Circulation Journal - February 7, 2017 Category: Cardiology Tags: Korean Circ J Source Type: research
Insurance, self-reported medication adherence and LDL cholesterol: The REasons for Geographic and Racial Differences in Stroke study
Despite efforts to increase health insurance coverage in the US, in 2015 29 million American adults were uninsured [1]. A majority of these individuals are under 64years old, racial minorities or have lower socioeconomic status [1]. Lack of health insurance is associated with greater barriers to preventive services [2] and treatment of both acute and chronic illnesses [3] resulting in worse reported health status [4]. Being uninsured also adversely impacts medication adherence [5] and the control of cardiovascular risk factors [6].
Source: International Journal of Cardiology - February 22, 2017 Category: Cardiology Authors: Matt Mefford, Monika M Safford, Paul Muntner, Raegan W Durant, Todd M Brown, Emily B Levitan Tags: Correspondence Source Type: research
Abstract 043: Health Insurance and the Risk of Incident Cardiovascular Disease in the Multi-Ethnic Study of Atherosclerosis Session Title: Poster Session I
Conclusions: The association of health insurance with CVD incidence varied by insurance group, and private insurance was associated with a lower risk of incident CVD. Further exploration of the features of health insurance coverage that impact CVD incidence may facilitate improvements in the primary prevention of CVD.
Source: Circulation: Cardiovascular Quality and Outcomes - March 31, 2017 Category: Cardiology Authors: Crim, M. T., Xie, J. X., Ko, Y.-A., Blumenthal, R. S., Blaha, M. J., Nasir, K., Budoff, M. J., Shaw, L. J. Tags: Session Title: Poster Session I Source Type: research
Tea consumption and risk of ischaemic heart disease
Conclusions
In this large prospective study, daily tea consumption was associated with a reduced risk of IHD.
Source: Heart - April 26, 2017 Category: Cardiology Authors: Li, X., Yu, C., Guo, Y., Bian, Z., Si, J., Yang, L., Chen, Y., Ren, X., Jiang, G., Chen, J., Chen, Z., Lv, J., Li, L., on behalf of the China Kadoorie Biobank Collaborative Group Tags: Open access Cardiac risk factors and prevention Source Type: research
Demographics, treatment and outcomes of atrial fibrillation in a developing country: the population-based TuRkish Atrial Fibrillation (TRAF) cohort
ConclusionThe TRAF cohort is the first population-based, whole-country cohort of AF epidemiology, quality of care and outcomes. It provides a unique opportunity to study the patterns, causes and impact of treatments on the incidence and outcomes of AF in a developing country.
Source: Europace - February 10, 2017 Category: Cardiology Source Type: research
Abstract P173: Target Blood Pressure in Elderly Hypertensive Patients: A Korean National Health Insurance Service Health Examinee Cohort Study Session Title: Onsite Poster Competition I With Reception
This study used the National Health Insurance Service Health examinee Sample Cohort. We selected subjects who were over the age of 60 years and who had received a newly diagnosis of hypertension (Korean Classification of Disease [KCD] codes I10–I13) from 2003 to 2006. Subjects who had previous major cardiovascular (CV) events, such as heart failure, ischemic heart disease, stroke, or end stage renal disease (ESRD) were excluded. The remaining 25,858 individuals were divided into three groups; 1) mean systolic blood pressure (SBP)
Source: Hypertension - September 14, 2017 Category: Cardiology Authors: Jiwon Seo, Sungha Park, Chan Joo Lee, Jinseub Hwang Tags: Poster Abstract Presentations Source Type: research
Abstract P304: Motivia(R), a Cardiovascular Disease Prevention Program, Decreases Hospitalization Length in Patients With High Risk for Developing Cardiovascular Event. Retrospective Analysis From 2010-2015 Session Title: Pregnancy and Preeclampsia and Developmental Programming of Cardiovascular Disease
Conclusions: Motivia® program, based on intensive treatment using TPA determination may benefit patients and health insurance by decreasing hospitality length.
Source: Hypertension - September 14, 2017 Category: Cardiology Authors: Hernan A Perez, Natalia Jorgensen, Santiago Torales, Andres Chianalino, Luis J Armando Tags: Poster Abstract Presentations Source Type: research
Abstract P478: Barriers to Health Care Access and Hypertension Treatment Among Us Adults With Self-reported Hypertension Session Title: Antihypertensive Drugs and Pharmacology, Patient-Provider-Healthcare System Issues, and Pediatric and Adolescent Hypertension
Conclusion: Although antihypertensive medication use is common among those with hypertension, this study found lower levels of reported antihypertensive medication use among those with perceived barriers to health care access.
Source: Hypertension - September 14, 2017 Category: Cardiology Authors: Jing Fang, Guijing Wang, Carma Ayala, Sal Lucido, Fleetwood Loustatol Tags: Poster Abstract Presentations Source Type: research
Dipeptidyl Peptidase-4 Inhibitors and Risk of Heart Failure in Patients With Type 2 Diabetes Mellitus: A Population-Based Cohort Study Original Articles
Conclusions:
Our findings suggest that DPP-4i use did not increase the risk of HF compared with sulfonylurea. In addition, the risks for cardiovascular outcomes were not elevated in DPP-4i–treated patients compared with sulfonylurea-treated patients.
Source: Circulation: Heart Failure - September 12, 2017 Category: Cardiology Authors: Kim, Y.-G., Yoon, D., Park, S., Han, S. J., Kim, D. J., Lee, K.-W., Park, R. W., Kim, H. J. Tags: Cardiovascular Disease, Diabetes, Type 2, Heart Failure Original Articles Source Type: research
The Use Pattern and Clinical Impact of New Antiplatelet Agents Including Prasugrel and Ticagrelor on 30-day Outcomes after Acute Myocardial Infarction in Korea: Korean Health Insurance Review and Assessment Data.
CONCLUSION: The use of new antiplatelet agents is rapidly increasing, and they have been used more commonly than clopidogrel since 2015. We demonstrated that new antiplatelet agents have a favorable effect on reducing 30-day mortality in AMI patients in Korea.
PMID: 29035430 [PubMed - as supplied by publisher]
Source: Korean Circulation Journal - October 18, 2017 Category: Cardiology Tags: Korean Circ J Source Type: research
Cardiovascular and Bleeding Risks in Acute Myocardial Infarction Newly Treated With Ticagrelor vs. Clopidogrel in Taiwan.
CONCLUSIONS: In real-world AMI Taiwanese patients, ticagrelor seemed to offer better anti-ischemic protection than clopidogrel, without an increase in the rate of major bleeding. A large-scale randomized trial is needed to assess the efficacy and safety of ticagrelor in East Asian AMI patients.
PMID: 29081474 [PubMed - as supplied by publisher]
Source: Circulation Journal - October 27, 2017 Category: Cardiology Authors: Lee CH, Cheng CL, Kao Yang YH, Chao TH, Chen JY, Li YH Tags: Circ J Source Type: research
Diuretic or Beta-Blocker for Hypertensive Patients Already Receiving ACEI/ARB and Calcium Channel Blocker
ConclusionAdding a diuretic may be better than adding a beta-blocker for treating hypertensive patients with prior CVA history who have already received ACEIs/ARBs and CCBs.
Source: Cardiovascular Drugs and Therapy - December 8, 2017 Category: Cardiology Source Type: research
